Dr. Mark Krawitz, M.D

NPI: 1659323194
Total Payments
$41.50
2019 Payments
$26.50
Companies
2
Transactions
3
Medicare Patients
6,093
Medicare Billing
$536,271

Payment Breakdown by Category

Food & Beverage$41.50 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $41.50 3 100.0%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $27.35 2 $0 (2019)
GlaxoSmithKline, LLC. $14.15 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2019 $26.50 2 GlaxoSmithKline, LLC. ($14.15)
2017 $15.00 1 Novartis Pharmaceuticals Corporation ($15.00)

All Payment Transactions

3 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
08/14/2019 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $14.15 General
Category: RESPIRATORY
02/07/2019 Novartis Pharmaceuticals Corporation DUREZOL (Drug) Food and Beverage In-kind items and services $12.35 General
Category: OPHTHALMOLOGY
11/09/2017 Novartis Pharmaceuticals Corporation DUREZOL (Drug) Food and Beverage In-kind items and services $15.00 General
Category: OPHTHALMOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 999 1,120 $195,600 $60,558
2022 12 1,657 2,502 $471,030 $157,457
2021 12 1,774 2,466 $449,865 $160,785
2020 12 1,663 2,242 $442,860 $157,472
Total Patients
6,093
Total Services
8,330
Medicare Billing
$536,271
Procedure Codes
47

All Medicare Procedures & Services

47 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
92014 Established patient complete exam of visual system Office 2023 260 289 $46,240 $24,508 53.0%
67210 Destruction of growth of retina using a laser Office 2023 18 25 $50,000 $10,980 22.0%
92134 Imaging of retina Office 2023 161 179 $21,480 $5,120 23.8%
76512 2d ultrasound scan of eye tissue and structures Office 2023 87 103 $25,500 $4,050 15.9%
92012 Established patient problem focused exam of visual system Office 2023 42 58 $6,670 $3,433 51.5%
92083 Exam of visual field with extended testing Office 2023 59 65 $11,050 $3,351 30.3%
92235 Exam of retinal blood vessels using a special camera after injection of a dye Office 2023 30 30 $9,000 $3,344 37.2%
92202 Extended exam of the back part of the eye with optic nerve drawing Office 2023 242 269 $13,450 $3,197 23.8%
92133 Imaging of optic nerve Office 2023 52 53 $6,360 $1,254 19.7%
92250 Photography of the retina Office 2023 37 38 $4,750 $1,073 22.6%
67820 Removal of eyelashes using forceps Office 2023 11 11 $1,100 $248.64 22.6%
92014 Established patient complete exam of visual system Office 2022 333 572 $91,520 $55,745 60.9%
67210 Destruction of growth of retina using a laser Office 2022 54 74 $148,000 $34,007 23.0%
92012 Established patient problem focused exam of visual system Office 2022 124 220 $25,300 $16,029 63.4%
92134 Imaging of retina Office 2022 222 365 $43,800 $11,701 26.7%
76512 2d ultrasound scan of eye tissue and structures Office 2022 138 217 $54,250 $8,785 16.2%
92235 Exam of retinal blood vessels using a special camera after injection of a dye Office 2022 55 67 $20,100 $7,730 38.5%
92083 Exam of visual field with extended testing Office 2022 118 142 $24,140 $7,694 31.9%
92202 Extended exam of the back part of the eye with optic nerve drawing Office 2022 318 498 $24,900 $6,319 25.4%
92250 Photography of the retina Office 2022 102 124 $15,500 $3,747 24.2%
92133 Imaging of optic nerve Office 2022 112 127 $15,240 $3,641 23.9%
67820 Removal of eyelashes using forceps Office 2022 49 63 $6,300 $1,281 20.3%
92020 Exam of the internal drainage system of eye Office 2022 32 33 $1,980 $778.96 39.3%
92014 Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits Office 2021 355 591 $94,560 $59,406 62.8%
67210 Laser destruction of retinal growth, 1 or more sessions Office 2021 50 65 $130,000 $31,004 23.8%

About Dr. Mark Krawitz, M.D

Dr. Mark Krawitz, M.D is a Ophthalmology healthcare provider based in Warren, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659323194.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Krawitz, M.D has received a total of $41.50 in payments from pharmaceutical and medical device companies, with $26.50 received in 2019. These payments were reported across 3 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($41.50).

As a Medicare-enrolled provider, Krawitz has provided services to 6,093 Medicare beneficiaries, totaling 8,330 services with total Medicare billing of $536,271. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.

Practice Information

  • Specialty Ophthalmology
  • Location Warren, NJ
  • Active Since 05/16/2006
  • Last Updated 10/26/2022
  • Taxonomy Code 207W00000X
  • Entity Type Individual
  • NPI Number 1659323194

Products in Payments

  • DUREZOL (Drug) $27.35
  • NUCALA (Biological) $14.15

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Ophthalmology Doctors in Warren